Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Postprandial lipid absorption in seven heterozygous carriers of deleterious variants of MTTP in two abetalipoproteinemic families.

Di Filippo M, Varret M, Boehm V, Rabès JP, Ferkdadji L, Abramowitz L, Dumont S, Lenaerts C, Boileau C, Joly F, Schmitz J, Samson-Bouma ME, Bonnefont-Rousselot D.

J Clin Lipidol. 2018 Oct 24. pii: S1933-2874(18)30423-9. doi: 10.1016/j.jacl.2018.10.003. [Epub ahead of print]

PMID:
30522860
2.

Medical biology in the face of the evolution of health care needs.

Dreux C, Maquart FX, Bonnefont-Rousselot D, Delpech M, Gueant JL, Le Bouc Y, Massoubre B, Porquet D, Rives N, Vigneron C.

Ann Biol Clin (Paris). 2018 Oct 1;76(5):485-491. doi: 10.1684/abc.2018.1370. Review.

PMID:
30154066
3.

Estimated GFR-specific 99th percentiles for high-sensitive cardiac troponin T based on the adjusted analytical change limit (adjACL) in hospitalized patients.

Monneret D, Hausfater P, Riou B, Bonnefont-Rousselot D.

Clin Chem Lab Med. 2018 Dec 19;57(2):e5-e7. doi: 10.1515/cclm-2018-0485. No abstract available.

PMID:
30004901
4.

Use of Resveratrol Self-Emulsifying Systems in T/C28a2 Cell Line as Beneficial Effectors in Cellular Uptake and Protection Against Oxidative Stress-Mediated Death.

Le Clanche S, Cheminel T, Rannou F, Bonnefont-Rousselot D, Borderie D, Charrueau C.

Front Pharmacol. 2018 May 24;9:538. doi: 10.3389/fphar.2018.00538. eCollection 2018.

5.

Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels.

Monneret D, Mestari F, Djiavoudine S, Bachelot G, Cloison M, Imbert-Bismut F, Bernard M, Hausfater P, Lacorte JM, Bonnefont-Rousselot D.

Scand J Clin Lab Invest. 2018 Sep;78(5):346-351. doi: 10.1080/00365513.2018.1471618. Epub 2018 May 15.

PMID:
29764220
6.

Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.

Palich R, Tubiana R, Abdi B, Mestari F, Guiguet M, Imbert-Bismut F, Katlama C, Bonnefont-Rousselot D, Isnard-Bagnis C.

J Antimicrob Chemother. 2018 Apr 24. doi: 10.1093/jac/dky112. [Epub ahead of print]

PMID:
29688533
7.

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

Mattina A, Rosenbaum D, Bittar R, Bonnefont-Rousselot D, Noto D, Averna M, Bruckert E, Giral P.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):517-523. doi: 10.1016/j.numecd.2018.01.012. Epub 2018 Feb 2.

PMID:
29525223
8.

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Peta V, Tse C, Perazzo H, Munteanu M, Ngo Y, Ngo A, Ramanujam N, Verglas L, Mallet M, Ratziu V, Thabut D, Rudler M, Thibault V, Schuppe-Koistinen I, Bonnefont-Rousselot D, Hainque B, Imbert-Bismut F, Merz M, Kullak-Ublick G, Andrade R, van Boemmel F, Schott E, Poynard T; Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière; Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium.

PLoS One. 2017 Dec 29;12(12):e0189436. doi: 10.1371/journal.pone.0189436. eCollection 2017.

9.

Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach.

Monneret D, Gellerstedt M, Bonnefont-Rousselot D.

Clin Chem Lab Med. 2018 Apr 25;56(5):685-696. doi: 10.1515/cclm-2017-0256.

PMID:
29176015
10.

Oxidative stress and the amyloid beta peptide in Alzheimer's disease.

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F.

Redox Biol. 2018 Apr;14:450-464. doi: 10.1016/j.redox.2017.10.014. Epub 2017 Oct 18. Review.

11.

Blood lipid tests in 2017.

Couderc R, Antar M, Bonnefont-Rousselot D, Paul JL, Therond P.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):646-652. doi: 10.1684/abc.2017.1303. Review.

12.

Impact of pH on Urine Chemistry Assayed on Roche Analyzers.

Cohen R, Alkouri R, Tostivint I, Djiavoudine S, Mestari F, Dever S, Atlan G, Devilliers C, Imbert-Bismut F, Bonnefont-Rousselot D, Monneret D.

Clin Lab. 2017 Oct 1;63(10):1749-1753. doi: 10.7754/Clin.Lab.2017.170409.

PMID:
29035440
13.

Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy.

Carillion A, Feldman S, Na N, Biais M, Carpentier W, Birenbaum A, Cagnard N, Loyer X, Bonnefont-Rousselot D, Hatem S, Riou B, Amour J.

PLoS One. 2017 Jul 20;12(7):e0180103. doi: 10.1371/journal.pone.0180103. eCollection 2017.

14.

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.

Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, Lacorte JM, Gastaldelli A, Schuppan D, Schattenberg JM, Hakkarainen A, Lundbom N, Jousilahti P, Männistö S, Keinänen-Kiukaanniemi S, Saltevo J, Anstee QM, Yki-Järvinen H.

Diabetologia. 2017 Oct;60(10):1873-1882. doi: 10.1007/s00125-017-4340-1. Epub 2017 Jun 29.

PMID:
28660493
15.

Effects of a Carbohydrate-, Glutamine-, and Antioxidant-Enriched Oral Nutrition Supplement on Major Surgery-Induced Insulin Resistance: A Randomized Pilot Study.

van Stijn MFM, Soeters MR, van Leeuwen PAM, Schreurs WH, Schoorl MG, Twisk JWR, De Bandt JP, Bonnefont-Rousselot D, Cynober L, Ackermans MT, Serlie MJ, Houdijk APJ.

JPEN J Parenter Enteral Nutr. 2017 May 1:148607117711691. doi: 10.1177/0148607117711691. [Epub ahead of print]

PMID:
28541810
16.

Diaphragmatic function is enhanced in fatty and diabetic fatty rats.

De Jong A, Carreira S, Na N, Carillion A, Jiang C, Beuvin M, Lacorte JM, Bonnefont-Rousselot D, Riou B, Coirault C.

PLoS One. 2017 Mar 22;12(3):e0174043. doi: 10.1371/journal.pone.0174043. eCollection 2017.

17.

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.

Bruckert E, Kalmykova O, Bittar R, Carreau V, Béliard S, Saheb S, Rosenbaum D, Bonnefont-Rousselot D, Thomas D, Emery C, Khoshnood B, Carrié A.

Atherosclerosis. 2017 Feb;257:130-137. doi: 10.1016/j.atherosclerosis.2017.01.015. Epub 2017 Jan 16.

PMID:
28131047
18.

Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors.

Bittar R, Aslangul É, Giral P, Assoumou L, Valantin MA, Kalmykova O, Federspiel MC, Cherfils C, Costagliola D, Bonnefont-Rousselot D; ANRS 126 study group.

C R Biol. 2017 Feb;340(2):109-113. doi: 10.1016/j.crvi.2016.11.004. Epub 2016 Dec 20.

19.

Introducing High-Sensitivity Cardiac Troponin T as a Biomarker of OSA-Related Cardiovascular Morbidity in Obesity Hypoventilation Syndrome.

Monneret D, Giral P, Bonnefont-Rousselot D, Roche F.

Chest. 2016 Dec;150(6):1408-1409. doi: 10.1016/j.chest.2016.08.1467. No abstract available.

PMID:
27938750
20.

Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.

Hansel B, Bonnefont-Rousselot D, Orsoni A, Bittar R, Giral P, Roussel R, Marre M, Mohammedi K, Bruckert E, Chapman MJ, Kontush A.

J Clin Lipidol. 2016 Sep-Oct;10(5):1172-81. doi: 10.1016/j.jacl.2016.05.008. Epub 2016 May 14.

PMID:
27678434

Supplemental Content

Loading ...
Support Center